
Tag: investing in Tilt


TILT Holdings Provides Preliminary Fourth Quarter Results, Operational Highlights and 2021 Outlook

TILT Holdings Subsidiary Jupiter Research Receives ISO 13485:2016 Medical Device Certification

TILT Holdings Upgraded to OTCQX® Best Market

TILT Holdings Completes Sale of Blackbird

TILT Holdings Provides Preliminary Third Quarter Results; Announces Senior Leadership Changes to Advance Corporate Strategy

TILT Holdings Announces Financial Results for the Three and Six-Months ended June 30, 2020

Jupiter Research Introduces “Dose-CTI” Metered Dosage Delivery
